Stem cell preconditioning for enhanced therapeutic efficacy: Translational challenges and strategic solutions

Stem cell preconditioning can enhance survival, trafficking, and paracrine activity, but promising preclinical enhancement has not yet translated into a comparably mature clinical evidence base.To evaluate the product development requirements for preconditioned stem cells and their extracellular vesicles (EVs) products, we propose a pharmaceutical product development framework, and identify priorities for future translational research.We integrated a comparative assessment of major preconditioning strategies and an analysis of registered clinical trials with product development principles.We also examined their derivative EV products derived from preconditioned stem cells and potential applications of artificial intelligence.The registry analysis identified a small, heterogeneous clinical landscape dominated by early-phase trials and limited use of matched unpreconditioned comparators, restricting assessment of the incremental contribution of preconditioning.We proposed a product lifecycle framework linking the quality target product profile to mechanism of action, critical quality attributes, potency assays, process standardization, good manufacturing practice manufacturing, scale-up, comparability, and risk management.For EV products, preconditioned source cell constitutes an upstream process variable, while the administered product requires specific characterization and potency assessment.Priorities included combined preconditioning methods, transparent reporting and validation of artificial intelligence approaches for optimization and monitoring.Stem cell preconditioning should be developed as a controlled manufacturing step, with quality and potency requirements tailored to the product and indication.This framework may guide the development of reproducible, scalable stem cells and EV products, while clinical studies with appropriate comparators remain necessary to establish the added therapeutic value of preconditioning.

Authors

Institutions

Publication Details

Journal
World Journal of Stem Cells
Published
2026-11-13
DOI
https://doi.org/10.4252/wjsc.127968
Primary Topic
Mesenchymal stem cell research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Stem cell preconditioning for enhanced therapeutic efficacy: Translational challenges and strategic solutions

Can Cui, Ke-Rui Huang, Zhou Yu, Han-Kun Su
World Journal of Stem Cells
Mesenchymal stem cell research
article

Stem cell preconditioning for enhanced therapeutic efficacy: Translational challenges and strategic solutions

Can Cui, Ke-Rui Huang, Zhou Yu, Han-Kun Su
article en

Abstract

Stem cell preconditioning can enhance survival, trafficking, and paracrine activity, but promising preclinical enhancement has not yet translated into a comparably mature clinical evidence base.To evaluate the product development requirements for preconditioned stem cells and their extracellular vesicles (EVs) products, we propose a pharmaceutical product development framework, and identify priorities for future translational research.We integrated a comparative assessment of major preconditioning strategies and an analysis of registered clinical trials with product development principles.We also examined their derivative EV products derived from preconditioned stem cells and potential applications of artificial intelligence.The registry analysis identified a small, heterogeneous clinical landscape dominated by early-phase trials and limited use of matched unpreconditioned comparators, restricting assessment of the incremental contribution of preconditioning.We proposed a product lifecycle framework linking the quality target product profile to mechanism of action, critical quality attributes, potency assays, process standardization, good manufacturing practice manufacturing, scale-up, comparability, and risk management.For EV products, preconditioned source cell constitutes an upstream process variable, while the administered product requires specific characterization and potency assessment.Priorities included combined preconditioning methods, transparent reporting and validation of artificial intelligence approaches for optimization and monitoring.Stem cell preconditioning should be developed as a controlled manufacturing step, with quality and potency requirements tailored to the product and indication.This framework may guide the development of reproducible, scalable stem cells and EV products, while clinical studies with appropriate comparators remain necessary to establish the added therapeutic value of preconditioning.

World Journal of Stem Cells
Central South University (CN), Xiangya Hospital Central South University (CN)
Good health and well-being
Mesenchymal stem cell research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon